HC Q study #5
See all studies
Early treatment study
Gautret et al., Int. J. of Antimicrobial Agents, 17 March 2020, doi:10.1016/j.ijantimicag.2020.105949 (Peer Reviewed)
Hydroxych loroquine and azithromycin as a treatment of COVID-19: results of an openlabel non-randomized clinical trial
HC Q significantly associated with viral load reduction / elimination, enhanced with AZ. This early and small trial has significant limitations, larger and more recent trials by the same group confirm the results.
Source   Share   Tweet
See all studies
Please send us corrections, updates, or comments.